Alar Pharmaceuticals Inc.
6785
Rank in Stocks
#17833
Alar Pharmaceuticals Inc., a drug development company, focuses on developing... Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.
Share Price
$2.30
Last synced: 2026-11-10
Market Cap
$153.75M
Change (1 day)
-1.31%
Change (1 year)
-72.88%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Alar Pharmaceuticals Inc. (6785)
Category
Healthcare
EPS for Alar Pharmaceuticals Inc. (6785)
EPS as of June 2026 TTM: $-0.03
According to Alar Pharmaceuticals Inc.'s latest financial reports, its current EPS (TTM) is $-0.03. At the end of 2025 the company had an EPS of $-0.04, a decrease compared to its 2024 EPS of $0.01.
EPS history for Alar Pharmaceuticals Inc. from 2017 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.03 | -15.75% |
| 2025 | $-0.04 | -562.20% |
| 2024 | $0.01 | -96.25% |
| 2023 | $0.22 | -2,018.42% |
| 2022 | $-0.01 | -72.06% |
| 2021 | $-0.04 | -59.92% |
| 2020 | $-0.10 | 56.86% |
| 2019 | $-0.06 | 1.25% |
| 2018 | $-0.06 | 150.39% |
| 2017 | $-0.03 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $1.69 | -5,114.84% |
US
|
|
| $1.93 | -5,829.38% |
SE
|
|
| $6.91 | -20,616.32% |
FR
|
|
| $0.02 | -157.86% |
HK
|
|
| $2.71 | -8,140.95% |
IT
|
Questions about Alar Pharmaceuticals Inc.'s earnings per share (EPS)
What is Alar Pharmaceuticals Inc.'s earnings per share (EPS)?
Alar Pharmaceuticals Inc.'s earnings per share (EPS) over the last twelve months is $-0.03, as of Jun 2026.
What was Alar Pharmaceuticals Inc.'s earnings per share (EPS) in 2025?
In 2025, Alar Pharmaceuticals Inc.'s earnings per share (EPS) was $-0.04, compared with $0.01 in 2024.
How has Alar Pharmaceuticals Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Alar Pharmaceuticals Inc.'s earnings per share (EPS) was highest in 2023 ($0.22) and lowest in 2020 ($-0.10).
How does Alar Pharmaceuticals Inc.'s earnings per share (EPS) compare with similar companies?
Alar Pharmaceuticals Inc.'s earnings per share (EPS) ($-0.03) is lower than that of all 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.91.